Sensitization of mice to real-life allergens or harmless antigen with the use of adjuvants will lead to the induction of DAMPs in the immune system. We have shown that the Th2-inducing adjuvant aluminum hydroxide or exposure of the airways to house dust mite leads to the release of DAMPs: uric acid, ATP, and IL-1. Exposure to DAMPs or PAMPs present in allergens or added to harmless allergens, such as the experimental allergen ovalbumin, induces several immune responses, including cellular infl ux and activation. Cellular infl ux can be analyzed by fl ow cytometry. Likewise, cellular activation can be assessed by measuring increased expression and release of chemokines and cytokines. These infl ammatory mediators can be analyzed by ELISA or confocal microscopy. Here, we describe the protocols for these assessments and a protocol that takes advantage of bone marrow chimeric mice to further elucidate mechanism.
Introduction
In addition to the necessary O 2 /CO 2 , one breath contains many allergens and pollutions, like diesel and ozone. Individuals that are susceptible to these agents mount Th2 responses to the respective allergens. Common allergens include house dust mite antigen, various molds, and many types of pollen [ 1 ] . Allergic infl ammation is characterized by an infl ux of eosinophils, goblet cell metaplasia, Th2 T cell responses, increased serum IgE levels, and, in the case of asthma, increased airway hyper-responsiveness. The development of Th2 responses is dependent on the innate arm of the immune system, which includes the release of both cytokines and chemokines by stromal cells and hematopoietic cells. These proinfl ammatory mediators can also be released by recruited cells, like neutrophils, monocytes, and dendritic cells (DCs) . DCs are at the gateway between innate and adaptive immunity. DCs can phagocytose antigens and process them for presentation to antigen-specifi c T cells, which initiates a proper immune response [ 1 , 2 ] . However, in the airway, the interaction between DCs and lung epithelial cells is crucial [ 3 ] . Lung epithelial cells release several chemokines and cytokines shortly after exposure to allergens or pollutions that recruit and mature DCs to induce a immune responses [ 4 ] . Allergens can be accompanied by pathogenassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) can be induced and produced by host cells. PAMPs and DAMPs can both act as adjuvants to further strengthen the immune response. DCs, macrophages, and epithelial cells in the lung can sense PAMPs and DAMPs by the use of several pattern recognition receptors (PRRs) on their surface, such as Tolllike receptors (TLRs), Nod-like receptors (NLRs), and purinergic receptors (P2X-and P2Y-receptors).
As an example of PAMPs, lipopolysaccharide (LPS) is a commonly used stimulus in experiments to induce maturation on DCs via TLR4 signaling. It even has been shown to induce Th2 sensitization to a harmless antigen, whereof the amount of LPS is able to shift the balance to Th1 or Th2 [ 5 , 6 ] . Another well-known DAMP, adenosine triphosphate (ATP), is able to signal on DCs via the P2X7 receptor [ 7 , 8 ] . TLR4 signaling on DCs will lead to NF-κB activation, which subsequently leads to the secretion of infl ammatory cytokines, such as pro-IL-1β and pro-IL-18. A second signal, like ATP binding, activates potassium effl ux via the P2X7R and, when combined with pannexin-1, leads to the activation of the NLRP3 infl ammasome. NLRP3 infl ammasome activation results in the activation of caspase-1. This enzyme cleaves pro-IL-1β and pro-IL-18 into their bioactive forms and these cytokines will be secreted [ 9 ] . Aluminum-containing adjuvants, which are used in many vaccines, stimulate the release of uric acid (UA). UA crystals are another proinfl ammatory DAMP that can directly activate the NLRP3 infl ammasome [ 10 , 11 ] . However, recently we have shown that UA does not need the NLRP3 infl ammasome or IL-1 axis to induce Th2 immunity. Instead, UA activation of the immune system for Th2 induction is dependent on spleen tyrosine kinase (Syk) and PI3-kinase delta signaling [ 12 , 13 ] .
Sensitization of mice to real-life allergens or harmless antigens with the use of adjuvants will lead to the induction of DAMPs by the immune system. We have shown that the Th2-inducing adjuvant aluminum hydroxide or exposure of the airways to house dust mite leads to the release of the DAMPs: uric acid, ATP, and IL-1. This release is measured in either the peritoneal lavage (PL), in the case of an intraperitoneal antigen injection combined with adjuvant, or the broncho-alveolar lavage (BAL), in the case of airway sensitization. Here, we describe a set of protocols to induce and analyze the release of different DAMPs and PAMPs with particular emphasis on ATP, IL-1, and UA.
The TLRs play an important role in the recognition of PAMPs. The TLR family in mice consists of 12 family members. TLR1, TLR2, TLR4, TLR5, and TLR6 are localized on the cell surface mainly recognizing microbial membrane components, such as LPS and fl agellin, whereas TLR3, TLR7, TLR8, and TLR9 are expressed within intracellular vesicles and recognize dsRNA, ssRNA, CPG, and DNA [ 14 ] . Downstream of TLR signaling, adaptor molecules like MyD88, BTK, IRAK4, IRAK1, and IRAK2 eventually lead to TRAF6 ubiquitination and NF-κB activation. Another activation pathway via TRAM/TRIF forms complexes with TBK1 and subsequently activates IRF3. Activation of IRF3 leads to type I IFN production [ 14 , 15 ] .
To study the role of these TLRs and their signaling molecules in allergic asthma models, various knockout strains are available as summarized in Table . 1 . Table 1  Mouse strains available to study the role of TLRs and signaling Multiple mouse strains are also available to study the role of DAMPs in allergic asthma ( Table 2 ) . Some well-known DAMPs that have been shown to have adjuvant activity are IL-1α, highmobility-group protein 1 (HMGB1) and ATP [ 16 -18 ] . For these, the danger signals are also defi ned receptors like IL-1RI, RAGE, and the P2X receptors. However, the receptors for many DAMPs are not known. For example, uric acid is a potent inducer of Th2 immunity [ 12 , 19 ] ; however, the receptor that senses uric acid has not been identifi ed. Therefore, to study the role of uric acid, uricase-defi cient mouse strains can be used.
Some DAMPs activate the intracellular NALP/IPAFinfl ammasomes [ 20 ] . For example, NLRP3 can be activated by uric acid crystals, alum adjuvant, and potassium effl ux via pannexin-1 hemichannels. Infl ammasome activation leads to recruitment of the adaptor molecule ASC and the subsequent activation of caspase-1, which is needed to cleave an assortment of procytokines into their bioactive forms [ 21 ] . Knockout mouse lines have proven to be vital for these studies.
Here, we describe methods used to evaluate DAMPs, with special emphasis on uric acid, during the induction of allergic airway infl ammation. We also describe methods to use DAMPs and PAMPs as adjuvants and protocols to evaluate cytokine and chemokine production. Finally, we detail the process of generating bone marrow chimera mice and steps to evaluate dendritic cell migration.
Materials
1. C57BL/6 or BALB/c mice can be obtained from certifi ed providers such as Harlan or Jackson Labs ( see Note 1 ).
2. Pipet for 50 μl administration (required for intratracheal/ intranasal administration).
3. Inhalation anesthesia administration station (preferentially for isofl urane).
4. Allergen-House Dust Mite Antigen (Greer Laboratories).
5. Allergen-Ovalbumin (OVA).
6. Adjuvant (Imject alum, Pierce).
7. Trachea catheter for BAL (23 G needle with a piece of PE50 tubing).
8. Suture: 3-0 silk thread.
9. 23 G needle with a 2.5 ml syringe for PL.
10. 0.5 mM EDTA/PBS.
11. Ice.
1. ATPlite™ Luminescence Assay System (Perkin Elmer).
2. Plate reader to detect luminescence.
1. Amplex ® Red Uric Acid/Uricase Assay Kit (Invitrogen).
1. Tissue-Tek (Sakura)/PBS solution, ratio 1:1 ( see Note 2 ).
2. Liquid nitrogen.
3. Cryostat.
4. Adhesive microscope slides and coverslips.
5. 4 % Paraformaldehyde (PFA) in PBS.
6. Block buffer: 1 % Blocking reagent (Roche) in PBS.
7. Anti-uric acid antibody (Abcam).
8. Goat-anti-rabbit Ig-Cy3 (Jackson Immunoresearch).
9. 4′,6-Diamidino-2-Phenylindole dihydrochloride (DAPI).
10. Polyvinyl alcohol mounting medium with DABCO ® , anti-fading. 6. Liquid nitrogen.
Peritoneal
7. Tissue homogenizer: IKA T10 rotor-stator homogenizer, with a 5 or a 7 mm generator.
8. 2 ml safe-lock tubes.
9. Cold lysis buffer: 20 mM Tris-HCl (pH 8.0), 0.14 M NaCl, 10 % glycerol (v/v), 1 mM PMSF, 1 mM sodium orthovanadate (Na 3 VO 4 ), 1 μM NaF, 40 mg/ml aprotinin, and 20 mg/ ml of leupeptin. Protease inhibitors should be prepared fresh on the day of use ( see Notes 3 and 4 ).
Igepal (US Biological).
11. NanoOrange protein quantitation assay (Invitrogen).
12. Plate reader to detect fl uorescence.
13. Eppendorf centrifuge.
14. Mini-labroller. 8. Plate reader.
1. Cryostat.
2. Tissue-Tek (Sakura)/PBS solution, ratio 1:1.
3. Liquid nitrogen.
5. PBS, pH 7.4-7.8.
Lung Homogenates

ELISA
MCP-1 Staining on Lung Sections
6. 4 % PFA at 4 °C (1:10 dilution of 37 % PFA in PBS).
7. 1 % Blocking reagent (Roche Applied Science) in PBS.
8. Normal donkey serum.
9. Normal goat serum and normal mouse serum.
10. Rat anti-MCP-1 (Abcam).
11. Donkey anti-rat conjugated with Cy3 (Jackson Immunoresearch).
12. 1 mg/ml of DAPI, stock.
13. Polyvinyl alcohol mounting medium with DABCO.
14. Confocal microscope.
1. Bone marrow donor mice of WT and KO origin.
2. Bone marrow acceptor mice of WT and KO origin, which will be irradiated.
3. Irradiation device (X-Rad 320, RPS).
Enrofl oxacin (antibiotic).
5. Heating lamp.
6. Inverted microscope.
7. Sterilized pestle and mortar.
8. Red blood cell (RBC)-lysis buffer: 0.15 M NH 4 Cl, 1 mM KHCO 3 , 0.1 mM Na 2 EDTA. Filter-sterilize before use.
1× HBSS and D-PBS.
10. 100 μm cell strainer.
11. 0.4 % Trypan blue solution, diluted 1:10 in 1× PBS.
12. Tubes, pipets, pipet tips, syringes, needles.
1. FACS buffer: 1× PBS, 0.25 % BSA, 0.5 mM EDTA, 0.05 % NaN 3 .
2. Low-binding fl exiplates.
3. OVA-Alexa Fluor 647.
DAPI.
5. Fixable live/dead Aqua.
6. FACS tubes.
7. 1× HBSS.
8. Multi-well plates and 15 ml tubes.
9. Tweezer and curved iris scissor.
10. 35 mm petri dishes.
11. 100 μm cell strainers.
12. Pasteur pipets. 
Methods
1. Anesthetize mice according to local guidelines.
2. Suspend the anesthetized mouse by the upper front teeth. This puts the mouse in a position where the head is vertical, and the body is suspended on the apparatus. It is an optimal position for the trachea to be vertical, which allows the liquid to effectively reach the airways.
3. Pull the tongue out of the mouth of the animal using blunt forceps. Hold the tongue on one side of the mouth while maintaining it in an extended position. This is extremely important, as it ensures that the mouse is not able to swallow and allows the allergen to reach the trachea.
4. Inject liquid just above the vocal cords in the mouth of the mouse. The mouse will gradually inhale the liquid.
5. Once the liquid is inhaled and the breathing rate has returned to normal, release the tongue.
6. If an injectable anesthesia is utilized, place the mouse on a heating mat to recover.
7. At the desired time point, euthanize mice and expose the trachea.
8. Insert the suture thread between the esophagus and the trachea.
9. With scissors, make a small incision into the trachea between the cartilage rings. The incision should be large enough to insert the catheter. Care should be taken to avoid cutting the trachea completely.
10. Insert the catheter into the trachea towards the lungs. Secure the catheter in place with the ligature.
11. Using EDTA/PBS at RT, wash the lung three times through the catheter with the same 1 ml. Place the retrieved BAL-fl uid in a 15-ml tube. The whole 1 ml must be injected and slowly retrieved ( see Note 5 ).
12. Keep the BAL fl uid on ice during the procedure.
13. Centrifuge BAL samples at 400 × g at 4 °C for 7 min and transfer the supernatant into a new tube ( see Note 6 ). It is very important
Intratracheal Injection of Allergens
that samples be kept cold. Samples should be used immediately for the measurement of ATP. For uric acid and IL-1 measurements, the supernatant can be stored at −20 °C until further analysis.
14. The measurement of ATP and uric acid in the supernatant is done according to the manufacturer's protocol.
1. Inject 10 μg of allergen, such as OVA, combined with 1 mg of alum in 500 μl of saline intraperitoneally (i.p.).
2. Sacrifi ce the mouse after 2 h by CO 2 inhalation ( see Note 7 ).
3. Gently cut the skin of the abdomen. Incisions should begin as close as possible to the leg area and care should be taken to avoid cutting the muscles of the abdomen.
4. Cut from the lowest part of the abdomen to the thorax and gently remove the skin from the muscles.
5. Inject 3 ml of warm EDTA/PBS i.p.
6. Gently massage/shake the mouse and recollect the EDTA/ PBS back into the syringe. Usually, 2-2.5 ml is collected.
7. Store on ice immediately.
8. Centrifuge PL samples at 400 × g at 4 °C for 7 min and transfer the supernatant into a new tube ( see Note 6 ). It is very important that samples be kept cold. Samples should be used immediately for the measurement of ATP. For uric acid and IL-1 measurement, the supernatants can be stored at −20 °C until further analysis.
9. The measurement of ATP and uric acid in the supernatant is done according to the manufacturer's protocol.
1. Infl ate the mouse lung via the trachea with 1 ml of TissueTek/PBS solution via the trachea-catheter used to collect the BAL.
2. Lungs should be snap frozen in liquid nitrogen and kept at −80 °C until further use.
3. Make 6-μm-thick cryosections.
4. Dry sections before storage at −80 °C or before staining.
5. Fix the slides in 4 % PFA for 10 min at room temperature ( see Note 8 ).
6. Wash the slides two times with PBS for 5 min per wash.
7. Block the slides with 10 % normal goat serum in block buffer for 10 min.
8. Wash the slides two times with PBS for 5 min per wash.
9. Incubate the sections for 1 h with anti-uric acid antibody (rabbit Ig) in block buffer ( see Note 9 ).
Intraperitoneal Injection of Allergens Combined with Adjuvant
Uric Acid Measurement on Cryosections
10. Wash the slides two times with PBS for 5 min per wash.
11. Incubate the sections for 30 min with goat anti-rabbit Ig-Cy3 in block buffer.
12. Wash the slides two times with PBS for 5 min per wash.
13. If other markers are to be evaluated, additional antibodies can be utilized to stain the sections.
14. Stain nuclei using DAPI (1 μg/ml in PBS) for 5 min.
15. Wash the slides two times with PBS for 5 min per wash.
16. Wash the slides with H 2 O for 5 min.
17. Mount slides with polyvinylethanol.
18. Analyze slides with a confocal microscope (Fig. 1 ).
1. Inject the allergens intratracheally and perform BAL as described in Subheading 3.1.
2. To analyze lung cellular infl ux and cytokine/chemokine responses to allergens, DAMPs or PAMPs, harvest the BAL and lung tissue at several time points after exposure. Samples should be collected at time points between 2 and 48 h.
3. BAL supernatant can be used for ELISA to determine the levels of cytokines and chemokines. The cells in the BAL can be analyzed for cellular infl ux by FACS-analysis (described in Subheading 3.9).
4. Open the chest of the mouse, dissect the left lobe of the lung, and collect it in the 2 ml tube. Snap-freeze the lung lobe in 5. Homogenize the lung. Add 400 μl of cold lysis buffer to the frozen lung samples and immediately homogenize them using a rotor-stator homogenizer equipped with a 5 or a 7 mm generator for 1.5 or 2 ml Eppendorf tubes. Tube sizes may extend up to 5 ml tubes, depending on lab availability. The speed of the homogenizer should be adjusted to avoid foaming. Foaming could alter the quality of the proteins and reduce the practical volume recovered. The homogenization is complete when no macroscopic pieces of lung are visible in the solution. Place the samples on ice until all of the samples are homogenized. 9. Store supernatant at −80 °C until ELISA is performed. Use the NanoOrange kit to measure and normalize the protein content.
Preparation of Lung Homogenates
1. Coat the ELISA plates with purifi ed antibody in an appropriate coating buffer overnight at 4 °C. For half-area plates, use 50 μl/well; otherwise double all volumes described below.
2. Wash the wells three times with 150 μl/well of wash buffer and empty wells by blotting the plate on an absorbent towel.
3. Block the uncoated spots in wells with 150 μl/well of 10 % FCS/PBS and incubate the plate for 1 h at room temperature.
4. Wash the wells once with 150 μl/well of wash buffer and empty the wells by blotting the plate on an absorbent towel.
5. Add 50 μl/well of samples, standards, and blank (in either duplicate or triplicate) and incubate the plate for 2-2.5 h at room temperature.
6. Wash the wells fi ve times with 150 μl/well of wash buffer and empty the wells by blotting the plate on an absorbent towel.
7. Add 50 μl/well of detection antibody diluted in 10 % FCS/ PBS. Incubate the plate for 1-2 h at room temperature.
8. Wash the wells fi ve times with 150 μl/well of wash buffer and empty the wells by blotting the plate on an absorbent towel. 3. Make 6-μm cryosections using a cryostat and store these sections at −80 °C. However, if the staining is to be performed on the same day, air-dry the sections for 1 h prior to staining. 6. Rinse slides with PBS for 2 min.
Cytokine
7. Add anti-MCP1 antibody diluted in 1 % blocking reagent to each slide and incubate for 1 h at room temperature ( see Note 9 ). The antibody dilutions should be optimized prior to use and can vary per lab.
8. Rinse slides with PBS for 2 min.
9. Add donkey anti-rat antibody diluted 1:50 in 1 % blocking reagent and incubate for 30 min at room temperature in the dark.
10. Rinse slides with PBS for 2 min.
11. Add DAPI diluted 1:1,000 in PBS and incubate for 5 min.
12. Rinse slides with PBS for 2 min and ddH 2 O for 2 min.
13. Mount slides with mounting medium and a coverslip and leave them overnight at room temperature to allow the mounting medium to polymerize. Analyze the slides under a confocal microscope (Fig. 2 ).
1. 8-10-week-old mice (WT and KO) are sublethally irradiated with 8-10 Gy (X-Rad 320, RPS) ( see Notes 11 and 12 ). The mice are subsequently placed back into their home cages for at least 4 h.
Chemokine Measurement by Confocal Microscopy
Bone Marrow Chimeric Mice
2. Isolate femurs and tibias from bone marrow donor mice and collect the bones in cold HBSS.
3. Incubate bones for 2 min with 70 % ethanol and wash twice with cold HBSS.
4. Transfer bones in a sterilized mortar and smash the bones in a small volume of HBSS with a pestle.
5. Rinse the pestle and the mortar with a larger volume of 1× HBSS and transfer the cell suspension through a 100 μm cell strainer, placed in a 50 ml tube.
6. Centrifuge the cells at 400 × g for 7 min at 4 °C.
7. Suspend the cell pellet in RBC lysis buffer (1 ml/# of mice). 14. Allergic asthma experiments can be initiated 10-12 weeks after irradiation. This will allow the long-lived alveolar macrophages in the lung to be replenished by the newly derived bone marrow.
1. Resuspend the PL or BAL cell pellet in 200-500 μl of FACS buffer.
2. Count an aliquot of the samples using Trypan blue and a hemacytometer.
3. Transfer 1 × 10 6 cells to a FACS fl exiplate (max 200 μl).
4. Centrifuge the plate for 3 min at 400 × g and 4 °C.
5. Remove the supernatant and add 40-50 μl of staining mix, which has been prepared with the monoclonal antibodies described in Table 3 in FACS buffer.
6. Incubate the supernatant for 30 min at 4 °C or 15 min at room temperature.
7. Add 150 μl of FACS buffer.
8. Centrifuge the plate for 3 min at 400 × g and 4 °C. 12. Data analysis is done according to Fig. 3 ( see Note 13 ).
DAMP and PAMPs as Adjuvants
1. Dissect the lung and LNs and keep them in HBSS on ice.
2. Cut the tissue into small pieces in a 35 mm petri dish using the iris scissors.
3. Transfer the pieces into a 15 ml tube and rinse the petri dish with digestion medium. For each lung half, use 500 μl of medium and for LNs use 200 μl per organ. Keep on ice until all of the samples are processed. 5. Filter the cell suspension over a 100 μm cell strainer and transfer the samples into new 15 ml tubes.
Dendritic Cell Migration
6. Centrifuge all samples at 4 °C at 400 × g for 7 min.
7. Resuspend the cell pellet in RBC-lysis buffer. Each LN should be resuspended in 200 μl and each lung half should be resuspended in 1 ml. Leave the cell suspensions on ice for 4 min and shake occasionally.
8. Add excess volumes of FACS-buffer and centrifuge all of the samples at 4 °C at 400 × g for 7 min.
9. Resupend the cell pellet in FACS-buffer and count the number of cells in each sample using Trypan blue and a hemacytometer.
10. Proceed with FACS-staining as described in Subheading 3.8 using antibodies described in Table 4 . 11. Before acquiring on the fl ow cytometer, samples should be fi ltered using a fi lter plate of tubes with a fi lter cap to prevent clogs during acquisition.
12. Data analysis is done according to Fig. 4 ( see Note 13 ). 
Notes
1. We would like to stress the importance of monitoring the health status of your animal facility. It is known that certain pathogens (containing PAMPs) will greatly infl uence the outcome of the measurements described throughout this protocol. As far as possible within your facility, housing specifi c pathogenfree (SPF) mice in individually ventilated cages (IVC) would be optimal.
Fig. 4 Gating strategy for DC migration in mediastinal LNs
2. Make solutions no more than 24 h prior to use and mix well before use. Air bubbles will interfere with cutting and interpreting the morphology of lung sections.
3. The cold lysis buffer described here is for the extraction of extracellular and intracellular proteins and is therefore adequate for cytokines and other messengers. It will also extract many transmembrane proteins, but in this case, it is recommended to confi rm the effi ciency of the technique with your specifi c transmembrane protein. If ineffective, another lysis buffer can be used, making sure not to include any detergent in the homogenization phase. Omitting the detergent will avoid foaming of the solution.
4. The described lysis buffer contains sodium orthovanadate and sodium fl uoride (NaF): these are phosphatase inhibitors. If you have no interest in protein phosphorylation (e.g., STAT proteins to assess activation of cytokine receptors), these reagents are dispensable in the buffer. Aprotinine and leupeptine are protease inhibitors and are necessary to avoid protein degradation.
If you do not want to analyze cytokines in the BAL, it is better
to take the BAL with three times 1 ml of PBS/EDTA (for a total of 3 ml).
6. Make sure that there are no contaminating cells in the supernatant as this will greatly infl uence your measurement. Cells are the source of the DAMPs.
7. Do not use injectable anesthetics via the peritoneal route, as they can negatively impact cell viability.
8. Make sure that the slides never run dry; this will infl uence the result of your staining.
9. Make sure to always take an extra section alone without a primary antibody, but stained with the secondary antibody to set the background on the confocal microscope. Lungs are full of autofl uorescent cells.
10. Depending on the techniques applied to the homogenate, some components of the lysis buffer (e.g., Igepal as a detergent) might interfere with the assay. The fi rst attempt should be to dilute the lysate, which should reduce the impact of the lysis buffer components. If this cannot be achieved, modifi cations of the lysis buffer can be envisaged for the specifi c protocol. However, for the procedures described here, using recommended dilutions, no interference is expected.
11. The dose of irradiation should be confi rmed in each lab. This dose is general enough to deplete all bone marrow cells in C57Bl/6 mice. However, mice on a BALB/c background are more sensitive to irradiation. Thus, it might be necessary to irradiate the mice twice with 4 Gy at a 4-h interval. The mice are then injected early the next morning with the new bone marrow.
12. Make sure that you have enough mice to make four groups with the following controls: WT into WT; KO into WT; WT into KO; and KO into KO. Irradiation induces changes to the immunological response of mice, which must be controlled for in the experiment. Take cells for compensation. This means that all fl uorochromes used in the mix are prepared as a single stain.
13. Take cells for fl uorescence minus one (FMO) control staining to optimize your gating strategy [ 22 ] . FMO samples contain all fl uorochromes except one. When placing your gate on the staining of the fl uorochrome missing in the FMO, the background fl uorescence is observed. By using FMO samples, you ensure that your gates are placed on positive cells and not on background fl uorescence induced by other fl uorochromes.
